Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial Study for the Use of Straberi Epistamp Needling Device to Treat Postinflammatory Hyperpigmentation (PIH)

NCT04740255 is registered in ClinicalTrials.gov with Universal Skincare Institute as lead sponsor.

NCT NCT04740255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04740255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial Study for the Use of Straberi Epistamp Needling Device to Treat Postinflammatory Hyperpigmentation (PIH)
Lead sponsor
Universal Skincare Institute
Phase
Not applicable
Overall status
Completed
Start date
December 23, 2022
Completion date
October 12, 2023
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postinflammatory hyperpigmentation